These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26236760)

  • 1. Update on biomarkers in neuromyelitis optica.
    Melamed E; Levy M; Waters PJ; Sato DK; Bennett JL; John GR; Hooper DC; Saiz A; Bar-Or A; Kim HJ; Pandit L; Leite MI; Asgari N; Kissani N; Hintzen R; Marignier R; Jarius S; Marcelletti J; Smith TJ; Yeaman MR; Han MH; Aktas O; Apiwattanakul M; Banwell B; Bichuetti D; Broadley S; Cabre P; Chitnis T; De Seze J; Fujihara K; Greenberg B; Hellwig K; Iorio R; Jarius S; Klawiter E; Kleiter I; Lana-Peixoto M; Nakashima ; O'Connor K; Palace J; Paul F; Prayoonwiwat N; Ruprecht K; Stuve O; Tedder T; Tenembaum S; Garrahan JP; Aires B; van Herle K; van Pelt D; Villoslada P; Waubant E; Weinshenker B; Wingerchuk D; Würfel J; Zamvil S
    Neurol Neuroimmunol Neuroinflamm; 2015 Aug; 2(4):e134. PubMed ID: 26236760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The progress of research on the immune pathogenesis and biomarkers in optic neuritis related to neuromyelitis optica].
    Liu WD; Yu MY; Jiang LB
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):228-233. PubMed ID: 30841690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for neuromyelitis optica.
    Chang KH; Ro LS; Lyu RK; Chen CM
    Clin Chim Acta; 2015 Feb; 440():64-71. PubMed ID: 25444748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
    Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
    Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
    Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
    Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
    van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
    Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
    Sepúlveda M; Armangué T; Sola-Valls N; Arrambide G; Meca-Lallana JE; Oreja-Guevara C; Mendibe M; Alvarez de Arcaya A; Aladro Y; Casanova B; Olascoaga J; Jiménez-Huete A; Fernández-Fournier M; Ramió-Torrentà L; Cobo-Calvo A; Viñals M; de Andrés C; Meca-Lallana V; Cervelló A; Calles C; Rubio MB; Ramo-Tello C; Caminero A; Munteis E; Antigüedad AR; Blanco Y; Villoslada P; Montalban X; Graus F; Saiz A
    Neurol Neuroimmunol Neuroinflamm; 2016 Jun; 3(3):e225. PubMed ID: 27144216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.
    Ringelstein M; Ayzenberg I; Harmel J; Lauenstein AS; Lensch E; Stögbauer F; Hellwig K; Ellrichmann G; Stettner M; Chan A; Hartung HP; Kieseier B; Gold R; Aktas O; Kleiter I
    JAMA Neurol; 2015 Jul; 72(7):756-63. PubMed ID: 25985228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
    Jarius S; Wildemann B
    Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
    Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
    J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review.
    Pereira WL; Reiche EM; Kallaur AP; Kaimen-Maciel DR
    J Neurol Sci; 2015 Aug; 355(1-2):7-17. PubMed ID: 26050520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
    Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link.
    Jarius S; Aktas O; Wildemann B
    Med Hypotheses; 2015 Nov; 85(5):628-30. PubMed ID: 26323247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: About one in a million.
    Daniëlle van Pelt E; Wong YYM; Ketelslegers IA; Siepman DA; Hamann D; Hintzen RQ
    Mult Scler J Exp Transl Clin; 2016; 2():2055217315625652. PubMed ID: 28607712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.